CareCloud 과거 순이익 실적
과거 기준 점검 5/6
CareCloud은 연평균 11.8%의 비율로 수입이 증가해 온 반면, Healthcare Services 산업은 수입이 21.8% 증가했습니다. 매출은 연평균 4.3%의 비율로 감소했습니다. CareCloud의 자기자본이익률은 45.9%이고 순이익률은 2.3%입니다.
핵심 정보
11.80%
순이익 성장률
11.90%
주당순이익(EPS) 성장률
| Healthcare Services 산업 성장률 | 1.72% |
| 매출 성장률 | -4.30% |
| 자기자본이익률 | 45.93% |
| 순이익률 | 2.30% |
| 최근 순이익 업데이트 | 30 Jun 2026 |
최근 과거 실적 업데이트
Recent updates
분석 기사 • Aug 09
CareCloud, Inc. (NASDAQ:CCLD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
It's been a good week for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, because the company has just released its...
내러티브 업데이트 • Jul 01
CCLD: AI Solutions And Margin Gains Will Support Credit-Funded Expansion
Analysts have trimmed their CareCloud price target from $3.25 to $2.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together point to a more conservative outlook for the stock. What's in the News for CareCloud CareCloud redeemed 100% of its 8.75% Series B Preferred Stock.
내러티브 업데이트 • Jun 16
CCLD: Balance Sheet Reshaping And 2026 Guidance Will Support Bullish Repricing
Analysts have adjusted their price target on CareCloud to $8.00, reflecting updated assumptions around revenue growth, profit margins, discount rate and future P/E that they consider better aligned with the company’s current outlook. What’s in the News for CareCloud CareCloud fully redeemed all outstanding 8.75% Series B Preferred Stock, funded with a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank.내러티브 업데이트 • Jun 02
CCLD: Capital Reshaping And 2026 Outlook Will Clarify Underlying Revenue Trends
Analysts have reduced their price target on CareCloud to $3.25, citing concern that recent acquisitions, including plans to acquire an aircraft for client visits, may be obscuring underlying revenue declines. What's in the News CareCloud redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank, as part of a multi year capital structure shift.내러티브 업데이트 • May 13
CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential
Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.분석 기사 • May 11
The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...
내러티브 업데이트 • Apr 29
CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.내러티브 업데이트 • Apr 14
CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.내러티브 업데이트 • Mar 31
CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.내러티브 업데이트 • Mar 17
CCLD: Higher Margins And New Contracts Will Support Future Upside
Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.내러티브 업데이트 • Mar 02
CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside
Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.내러티브 업데이트 • Feb 16
CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential
Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.분석 기사 • Feb 04
Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)
You may think that with a price-to-sales (or "P/S") ratio of 0.9x CareCloud, Inc. ( NASDAQ:CCLD ) is a stock worth...내러티브 업데이트 • Feb 02
CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential
Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.Seeking Alpha • Jan 29
CareCloud: Undervalued AI Play In Healthcare IT
Summary CareCloud is transitioning from an RCM provider to AI-driven healthcare IT, targeting higher-margin recurring revenues. I assign CCLD a buy rating with a 1-year price target of $4.3, implying 48% upside from $2.9. Recent performance shows six consecutive quarters of GAAP profitability, strong cost control, and solid operating cash flow. Key risks include 2026 state AI regulations, which may limit adoption of CCLD’s new AI voice solutions. Read the full article on Seeking Alpha내러티브 업데이트 • Jan 19
CCLD: Cost Controls And AI Automation Will Support Future Repricing
Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.내러티브 업데이트 • Jan 05
CCLD: Cost Controls And New AI Offering Will Support Future Upside
Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.내러티브 업데이트 • Dec 15
CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher
Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.내러티브 업데이트 • Dec 01
CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum
CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.내러티브 업데이트 • Nov 17
CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability
CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.분석 기사 • Aug 26
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise
Despite an already strong run, CareCloud, Inc. ( NASDAQ:CCLD ) shares have been powering on, with a gain of 30% in the...분석 기사 • May 01
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise
Those holding CareCloud, Inc. ( NASDAQ:CCLD ) shares would be relieved that the share price has rebounded 33% in the...
새로운 내러티브 • Apr 12
CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities
AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.분석 기사 • Mar 16
Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its annual...분석 기사 • Mar 13
Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders won't be pleased to see that the share price has had a very rough month...분석 기사 • Feb 19
CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...분석 기사 • Jan 18
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...분석 기사 • Nov 13
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders have had their patience rewarded with a 34% share price jump in the last...분석 기사 • Oct 07
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Aug 31
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...분석 기사 • Jul 13
CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...분석 기사 • Jun 27
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • May 22
CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders would be excited to see that the share price has had a great month...분석 기사 • Mar 22
CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate
Key Insights CareCloud's estimated fair value is US$1.92 based on 2 Stage Free Cash Flow to Equity CareCloud is...분석 기사 • Mar 22
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...분석 기사 • Feb 02
Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding
The CareCloud, Inc. ( NASDAQ:CCLD ) share price has softened a substantial 25% over the previous 30 days, handing back...분석 기사 • Jan 30
Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Dec 19
CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...분석 기사 • Sep 28
Is CareCloud (NASDAQ:CCLD) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...매출 및 비용 세부 내역
매출 및 비용 세부 내역
CareCloud가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 30 Jun 26 | 129 | 3 | 26 | 9 |
| 31 Mar 26 | 124 | 4 | 25 | 8 |
| 31 Dec 25 | 120 | 4 | 23 | 6 |
| 30 Sep 25 | 114 | 2 | 22 | 5 |
| 30 Jun 25 | 112 | 0 | 22 | 4 |
| 31 Mar 25 | 113 | -4 | 22 | 4 |
| 31 Dec 24 | 111 | -4 | 22 | 4 |
| 30 Sep 24 | 111 | -52 | 24 | 4 |
| 30 Jun 24 | 112 | -58 | 26 | 4 |
| 31 Mar 24 | 113 | -62 | 29 | 5 |
| 31 Dec 23 | 117 | -64 | 31 | 5 |
| 30 Sep 23 | 121 | -20 | 32 | 5 |
| 30 Jun 23 | 126 | -16 | 33 | 5 |
| 31 Mar 23 | 133 | -12 | 33 | 4 |
| 31 Dec 22 | 139 | -10 | 34 | 4 |
| 30 Sep 22 | 144 | -7 | 34 | 3 |
| 30 Jun 22 | 148 | -6 | 34 | 3 |
| 31 Mar 22 | 145 | -9 | 33 | 3 |
| 31 Dec 21 | 140 | -11 | 33 | 4 |
| 30 Sep 21 | 134 | -15 | 31 | 7 |
| 30 Jun 21 | 128 | -18 | 31 | 9 |
| 31 Mar 21 | 113 | -23 | 29 | 9 |
| 31 Dec 20 | 105 | -23 | 29 | 9 |
| 30 Sep 20 | 89 | -21 | 26 | 7 |
| 30 Jun 20 | 74 | -16 | 23 | 5 |
| 31 Mar 20 | 71 | -11 | 22 | 3 |
| 31 Dec 19 | 64 | -7 | 19 | 1 |
| 30 Sep 19 | 65 | -8 | 21 | 1 |
| 30 Jun 19 | 65 | -9 | 21 | 1 |
| 31 Mar 19 | 57 | -8 | 19 | 1 |
| 31 Dec 18 | 51 | -7 | 18 | 1 |
| 30 Sep 18 | 42 | -6 | 16 | 1 |
| 30 Jun 18 | 33 | -4 | 13 | 1 |
| 31 Mar 18 | 32 | -5 | 12 | 1 |
| 31 Dec 17 | 32 | -8 | 13 | 1 |
| 30 Sep 17 | 32 | -11 | 13 | 1 |
| 30 Jun 17 | 30 | -11 | 13 | 1 |
| 31 Mar 17 | 28 | -10 | 13 | 1 |
| 31 Dec 16 | 24 | -10 | 13 | 1 |
| 30 Sep 16 | 21 | -6 | 12 | 1 |
| 30 Jun 16 | 21 | -6 | 12 | 1 |
| 31 Mar 16 | 22 | -6 | 12 | 1 |
| 31 Dec 15 | 23 | -5 | 12 | 1 |
| 30 Sep 15 | 25 | -5 | 13 | 1 |
양질의 수익: CCLD는 고품질 수익을 보유하고 있습니다.
이익 마진 증가: CCLD의 현재 순 이익률 (2.3%)은 지난해 (0.02%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: CCLD는 지난 5년 동안 흑자전환하며 연평균 11.8%의 수익 성장을 기록했습니다.
성장 가속화: 지난 1년간 CCLD 의 수익 증가율(17288.2%)은 연간 평균(11.8%)을 초과합니다.
수익 대 산업: CCLD의 지난 1년 수익 증가율(17288.2%)은 Healthcare Services 업계의 14.8%를 상회했습니다.
자기자본이익률
높은 ROE: CCLD의 자본 수익률(45.93%)은 뛰어남이지만 높은 부채 수준으로 인해 왜곡되어 있습니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/09/09 13:30 |
| 종가 | 2026/09/09 00:00 |
| 수익 | 2026/06/30 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
CareCloud, Inc.는 8명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Keay Nakae | Chardan Capital Markets, LLC |
| Eugene Mannheimer | Colliers Securities |